Cost-effectiveness analysis of docetaxel versus weekly paclitaxel in adjuvant treatment of regional breast cancer in New Zealand. [electronic resource]
Producer: 20150409Description: 707-24 p. digitalISSN:- 1179-2027
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Cost-Benefit Analysis
- Docetaxel
- Drug Administration Schedule
- Female
- Health Care Costs
- Humans
- Markov Chains
- Monte Carlo Method
- Neoplasm Staging
- New Zealand
- Paclitaxel -- administration & dosage
- Quality-Adjusted Life Years
- Survival Analysis
- Taxoids -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.